Delivery Order SPE2DB20D3103-SPE2DB24FP5N5

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,464.52 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $16,657.93 and a completion date of December 6, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 90 mg/mL syringes. The $44,847.53 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This federal contract award, valued at $17,355.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty medication, with an ultimate completion date of December 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $114,787.52, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a completion date of July 11, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The delivery order has a ceiling value of $76,389.65 and is a firm fixed price contract. The order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
This federal contract award, valued at $17,934.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,696.41, is for the delivery of STELARA 90 MG/ML syringes. It is a firm fixed price contract with a period of performance through February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP5N5
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The delivery order, valued at $15,667.56, has a firm fixed price and an ultimate completion date of July 17, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/15/24, 9:43 PM